APAC offers stability in an increasing challenging global geopolitical environment for clinical stage drug development.

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

Pharmaceutical firms that specialize in utilizing AI to speed up the drug discovery process are soaring today.

Where can researchers look for a beacon of hope amid trying times in the pharmaceutical industry? Read on for answers.

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

The field of drug discovery faces many time-honored challenges. These include high costs, long development times and high rates of failure. The rise of artificial intelligence (AI) technology has been ...

3 CDMOs offer a wide range of comprehensive services to pharmaceutical companies, some of which can include supporting formulation development, upscaling current drug processes, clinical trial ...

Luckily, the hiring process proceeded smoothly and Charles van Zyl joined as chief executive from Belgian pharma company UCB ...

That process is when manufacturers figure out what compounds should qualify as candidates for new medicines. The pharmaceutical company, which makes drugs like Lantus insulin jabs and Plavix blood ...